Medicina
Facultat
Università di Udine
Udine, ItaliaPublicacions en col·laboració amb investigadors/es de Università di Udine (55)
2023
-
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255
-
Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward
Expert Opinion on Biological Therapy, Vol. 23, Núm. 5, pp. 407-418
-
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
Critical Care, Vol. 27, Núm. 1
-
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults
Journal of Affective Disorders, Vol. 326, pp. 249-261
2022
2021
-
Erratum: Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 (Journal of Perinatal Medicine (2020) 48:9 (950-958) DOI: 10.1515/jpm-2020-0355)
Journal of Perinatal Medicine
-
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 12, pp. 2597-2604
-
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection
Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 232-241
-
The Fall in Antibody Response to SARS-CoV-2: A Longitudinal Study of Asymptomatic to Critically Ill Patients up to 10 Months after Recovery
Journal of Clinical Microbiology, Vol. 59, Núm. 11
2020
-
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
Clinical Microbiology and Infection, Vol. 26, Núm. 8, pp. 1024-1033
-
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
Cancer Research, Vol. 80, Núm. 3, pp. 624-638
-
Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child–Pugh B or C Liver Disease: A Case–Control Retrospective Study
Infectious Diseases and Therapy, Vol. 9, Núm. 1, pp. 151-163
-
Factors associated with the development of septic shock in patients with candidemia: A post hoc analysis from two prospective cohorts
Critical Care, Vol. 24, Núm. 1
-
Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19
Journal of Perinatal Medicine, Vol. 48, Núm. 9, pp. 950-958
2019
-
Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis
Mycoses, Vol. 62, Núm. 5, pp. 441-449
-
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study
BMJ Open, Vol. 9, Núm. 5
-
Influence of age on the clinical efficacy of tigecycline in severely ill patients
Journal of Global Antimicrobial Resistance, Vol. 18, pp. 199-206
-
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Annals of Oncology, Vol. 30, Núm. 5, pp. 766-773